View All Blog Posts

Biopharmaceutical Innovators Launch “Health Forward” to Highlight Innovation and Health Solutions

The innovative biopharmaceutical sector in the Middle East and North Africa is working with stakeholders throughout the region to make new medicines and better health care available to patients. Governments are making practical improvements and partnering with the private sector to drive innovation and to improve care.

The Health Forward initiative will share ideas and solutions that can advance innovation in the Middle East and North Africa and draw attention to unmet medical needs in the region. The collaboration will highlight successful public-private partnerships and case studies and address policies that could undermine innovation and private sector investment.

Data shows that life expectancy in MENA has increased by nearly 58% in recent decades – from only 47 years in 1960 to nearly 71 years in 2016. It is estimated that new treatments accounted for as much as 40% of the increase in life expectancies from 1986-2001, with some estimates as high as 73% in recent years.

But non-communicable diseases (NCDs) like heart disease, diabetes, and cancer threaten patient health and strain local budgets. To continue to see improved health outcomes and combat rising rates of NCDs, we look forward to continuing to work with countries across the region to invest in health and promote policies that advance innovation and ensure patient access to life saving treatments and cures.


Recognizing World IP Day Across the Middle East and North Africa

With an expanding labor force and burgeoning economic opportunities, it’s important for leaders in the Middle East and North Africa (MENA) to embrace robust approaches to intellectual property (IP) that encourage investment in innovation. This World IP Day, we explore the theme “Women and IP: Accelerating Innovation and Creativity,” highlighting the essential role of IP

Global Investments in Science and Innovation were Resilient during COVID-19

A new report, Global Innovation Index 2022, from the World Intellectual Property Organization (WIPO) indicates that research and development (R&D) investments thrived at the height of the COVID-19 pandemic in 2020 and continued to boom in 2021. This spike in innovation occurred despite the global recession and economic lockdowns in many countries, pointing to the importance of innovation for pandemic solutions and recovery.

Opportunities for Progress

Explore policy-related opportunities for governments, health officials and companies operating in the MENA health sector.

Learn more